PLP2 Expression as a Prognostic and Therapeutic Indicator in High-Risk Multiple Myeloma

被引：6

作者：

Bai, Hua ^{[1
]}

Zhu, Yudi ^{[1
]}

Xu, Peipei ^{[1
]}

Chen, Bing ^{[1
]}

机构：

[1] Nanjing Med Univ, Clin Coll, Nanjing Drum Tower Hosp, Dept Hematol, Nanjing 210008, Peoples R China

来源：

BIOMED RESEARCH INTERNATIONAL | 2020年 / 2020卷

关键词：

INTERNATIONAL STAGING SYSTEM; GENE-EXPRESSION; MOLECULAR CLASSIFICATION; PROTEOLIPID PROTEIN-2; CELL-PROLIFERATION; OVEREXPRESSION; STRATIFICATION;

D O I：

10.1155/2020/4286101

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Multiple myeloma (MM) is a devastating cancer with a highly heterogeneous outcome. Because of the heterogeneity of myeloma cells, risk stratification is important for making therapeutic regimens. Nevertheless, no immunohistochemical predictive and prognostic marker has been constructed yet. In the present study, we explored the prognostic value of proteolipid protein 2 (PLP2) in MM patients using immunohistochemistry (IHC). We assessed PLP2 expression in bone marrow (BM) biopsy specimens obtained from 87 newly diagnosed MM (NDMM) patients. Correlations between PLP2 expression and clinicopathological features were analyzed. PLP2 expression was present in high-risk MM patients, which was increased with disease progression and poor prognosis. PLP2 was increasing in parallel with high beta-2 microglobulin (beta 2-MG) and lactate dehydrogenase (LDH). Furthermore, MM patients with low PLP2 expression could achieve a favorable treatment response. PLP2 may be a novel biomarker for prognostic prediction and a therapeutic target for anti-MM treatments.

引用

页数：8

共 35 条

[1] BAG3 regulates multiple myeloma cell proliferation through FOXM1/Rb/E2F axis [J].

Bai, Hua ;

Chen, Bing .

CANCER GENE THERAPY, 2020, 27 (1-2) :108-111

[2] TRPV2-induced Ca2+-calcineurin-NFAT signaling regulates differentiation of osteoclast in multiple myeloma [J].

Bai, Hua ;

Zhu, Huayuan ;

Yan, Qing ;

Shen, Xuxing ;

Lu, Xiupan ;

Wang, Juejin ;

Li, Jianyong ;

Chen, Lijuan .

CELL COMMUNICATION AND SIGNALING, 2018, 16

[3] Prognostic factor analyses of myeloma survival with intergroup trial S9321 (INT 0141): examining whether different variables govern different time segments of survival [J].

Barlogie, Bart ;

Bolejack, Vanessa ;

Schell, Michael ;

Crowley, John .

ANNALS OF HEMATOLOGY, 2011, 90 (04) :423-428

[4] Bortezomib sensitizes multiple myeloma to NK cells via ER-stress-induced suppression of HLA-E and upregulation of DR5 [J].

Carlsten, Mattias ;

Namazi, Ali ;

Reger, Robert ;

Levy, Emily ;

Berg, Maria ;

St Hilaire, Cynthia ;

Childs, Richard W. .

ONCOIMMUNOLOGY, 2019, 8 (02)

[5] Proteolipid Protein 2 Overexpression Indicates Aggressive Tumor Behavior and Adverse Prognosis in Human Gliomas [J].

Chen, Yi-Hsuan ;

Hueng, Dueng-Yuan ;

Tsai, Wen-Chiuan .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)

[6] IMWG consensus on risk stratification in multiple myeloma [J].

Chng, W. J. ;

Dispenzieri, A. ;

Chim, C-S ;

Fonseca, R. ;

Goldschmidt, H. ;

Lentzsch, S. ;

Munshi, N. ;

Palumbo, A. ;

Miguel, J. S. ;

Sonneveld, P. ;

Cavo, M. ;

Usmani, S. ;

Durie, B. G. M. ;

Avet-Loiseau, H. .

LEUKEMIA, 2014, 28 (02) :269-277

[7] Loss of MiR-664 Expression Enhances Cutaneous Malignant Melanoma Proliferation by Upregulating PLP2 [J].

Ding, Zhenhua ;

Jian, Sun ;

Peng, Xuebiao ;

Liu, Yimin ;

Wang, Jianyu ;

Zheng, Li ;

Ou, Chengshan ;

Wang, Yinghui ;

Zeng, Weixia ;

Zhou, Meijuan .

MEDICINE, 2015, 94 (33) :e1327

[8] Reduced expression of proteolipid protein 2 increases ER stress-induced apoptosis and autophagy in glioblastoma [J].

Feng, Zichao ;

Zhou, Wenjing ;

Wang, Jiwei ;

Qi, Qichao ;

Han, Mingzhi ;

Kong, Yang ;

Hu, Yaotian ;

Zhang, Yulin ;

Chen, Anbin ;

Huang, Bin ;

Chen, Anjing ;

Zhang, Di ;

Li, Wenjie ;

Zhang, Qing ;

Bjerkvig, Rolf ;

Wang, Jian ;

Thorsen, Frits ;

Li, Xingang .

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (05) :2847-2856

[9] International Myeloma Working Group molecular classification of multiple myeloma: spotlight review [J].

Fonseca, R. ;

Bergsagel, P. L. ;

Drach, J. ;

Shaughnessy, J. ;

Gutierrez, N. ;

Stewart, A. K. ;

Morgan, G. ;

Van Ness, B. ;

Chesi, M. ;

Minvielle, S. ;

Neri, A. ;

Barlogie, B. ;

Kuehl, W. M. ;

Liebisch, P. ;

Davies, F. ;

Chen-Kiang, S. ;

Durie, B. G. M. ;

Carrasco, R. ;

Sezer, Orhan ;

Reiman, Tony ;

Pilarski, Linda ;

Avet-Loiseau, H. .

LEUKEMIA, 2009, 23 (12) :2210-2221

[10] Impaired bortezomib binding to mutant β5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells [J].

Franke, N. E. ;

Niewerth, D. ;

Assaraf, Y. G. ;

van Meerloo, J. ;

Vojtekova, K. ;

van Zantwijk, C. H. ;

Zweegman, S. ;

Chan, E. T. ;

Kirk, C. J. ;

Geerke, D. P. ;

Schimmer, A. D. ;

Kaspers, G. J. L. ;

Jansen, G. ;

Cloos, J. .

LEUKEMIA, 2012, 26 (04) :757-768

← 1 2 3 4 →